Drawing for CSL

USPTO serial 90027916

CSL

Reviewed by CopyMark Law Group

Reg. 6732486Status 700Registered
Filing date
Status date
Registration date
May 24, 2022
Examiner
BELLOTTI, CHRISTINA L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CSL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 THOMAS JEFFERSON STREET, NWSUITE 400WASHINGTON, DC 20007

Goods and services

ClassDescriptionStatusFirst use
035Promoting awareness of blood diseases, illnesses and conditions; promoting awareness of vaccines and related illnessesACTIVE—
041Educational services, namely, conducting classes, seminars, conferences, and workshops in the fields of pharmaceuticals, vaccines, biotechnology, biotherapy, immunology, rare diseases and blood conditionsACTIVE—
042Medical Research; Scientific Research in the field of vaccines and medicines; Scientific Research and Development in the field of vaccines and medicines; pharmaceutical research and development; research and development of vaccines and medicines; research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceutical preparations for gene therapyACTIVE—
044Medical information servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 24, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 24, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 12, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 11, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 23, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 18, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 1, 2022IUAFUSE AMENDMENT FILED—
Feb 1, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 3, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 8, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 8, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 19, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 4, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 4, 2021XAECEXAMINER'S AMENDMENT ENTERED—
May 4, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 4, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
May 4, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 19, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 19, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 19, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 29, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 5, 2020DOCKASSIGNED TO EXAMINER—
Jul 28, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 3, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance